Radiotherapy and concurrent chemoradiotherapy are general strategies for NPC; however, we found resistance to both radiotoxicity and chemotoxicity in NPC cells with high ANXA2 expression. This evidence concerns the gene ANXA2 and nasopharyngeal carcinoma.